GR920300134T1 - - Google Patents

Info

Publication number
GR920300134T1
GR920300134T1 GR920300134T GR920300134T GR920300134T1 GR 920300134 T1 GR920300134 T1 GR 920300134T1 GR 920300134 T GR920300134 T GR 920300134T GR 920300134 T GR920300134 T GR 920300134T GR 920300134 T1 GR920300134 T1 GR 920300134T1
Authority
GR
Greece
Application number
GR920300134T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR920300134T1 publication Critical patent/GR920300134T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082Hepadnaviridae, e.g. hepatitis B virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GR920300134T 1991-01-11 1993-03-16 GR920300134T1 (US20090163788A1-20090625-C00002.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9100273A FR2671554A1 (fr) 1991-01-11 1991-01-11 Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b.

Publications (1)

Publication Number Publication Date
GR920300134T1 true GR920300134T1 (US20090163788A1-20090625-C00002.png) 1993-03-16

Family

ID=9408604

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920300134T GR920300134T1 (US20090163788A1-20090625-C00002.png) 1991-01-11 1993-03-16

Country Status (6)

Country Link
EP (1) EP0494825A1 (US20090163788A1-20090625-C00002.png)
JP (1) JPH05230097A (US20090163788A1-20090625-C00002.png)
DE (1) DE494825T1 (US20090163788A1-20090625-C00002.png)
ES (1) ES2042481T1 (US20090163788A1-20090625-C00002.png)
FR (1) FR2671554A1 (US20090163788A1-20090625-C00002.png)
GR (1) GR920300134T1 (US20090163788A1-20090625-C00002.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1338310A (zh) * 2000-08-10 2002-03-06 清华大学 一种猪瘟病毒表位疫苗及其制备方法
EP1308730B1 (en) * 2000-08-11 2011-12-28 Advanced Life Science Institute, Inc. Method of detecting or assaying hbv
CN1339320A (zh) * 2000-08-18 2002-03-13 清华大学 一种艾滋病疫苗及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56026B1 (en) * 1982-10-19 1991-03-27 Cetus Corp Cysteine-depleted muteins of biologically active proteins
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
DE68929273T2 (de) * 1988-08-24 2001-07-05 American Cyanamid Co Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung

Also Published As

Publication number Publication date
FR2671554A1 (fr) 1992-07-17
EP0494825A1 (fr) 1992-07-15
ES2042481T1 (es) 1993-12-16
JPH05230097A (ja) 1993-09-07
DE494825T1 (de) 1993-01-14

Similar Documents

Publication Publication Date Title
EP0531653A3 (US20090163788A1-20090625-C00002.png)
EP0539116A3 (US20090163788A1-20090625-C00002.png)
FR2673017B1 (US20090163788A1-20090625-C00002.png)
FR2673394B1 (US20090163788A1-20090625-C00002.png)
EP0534777A3 (US20090163788A1-20090625-C00002.png)
FR2676353B1 (US20090163788A1-20090625-C00002.png)
FR2674176B1 (US20090163788A1-20090625-C00002.png)
FR2674288B1 (US20090163788A1-20090625-C00002.png)
FR2688779B1 (US20090163788A1-20090625-C00002.png)
FR2677119B1 (US20090163788A1-20090625-C00002.png)
FR2675000B1 (US20090163788A1-20090625-C00002.png)
FR2677254B1 (US20090163788A1-20090625-C00002.png)
FR2675618B1 (US20090163788A1-20090625-C00002.png)
FR2674583B1 (US20090163788A1-20090625-C00002.png)
FR2672876B1 (US20090163788A1-20090625-C00002.png)
FR2675750B1 (US20090163788A1-20090625-C00002.png)
GR920300134T1 (US20090163788A1-20090625-C00002.png)
FR2677334B1 (US20090163788A1-20090625-C00002.png)
FR2671715B1 (US20090163788A1-20090625-C00002.png)
FR2675912B1 (US20090163788A1-20090625-C00002.png)
JPH0498603U (US20090163788A1-20090625-C00002.png)
FR2672342B1 (US20090163788A1-20090625-C00002.png)
ECSM91528U (US20090163788A1-20090625-C00002.png)
EP0533129A3 (US20090163788A1-20090625-C00002.png)
EP0546832A3 (US20090163788A1-20090625-C00002.png)